Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of an Early Intensive Blood Pressure-Lowering Strategy Using Remifentanil and Dexmedetomidine in Patients With Spontaneous Intracerebral Hemorrhage: A Multicenter, Prospective, Superiority, Randomized Controlled Trial

NCT07695220 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Southern Medical University as lead sponsor.

NCT NCT07695220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07695220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of an Early Intensive Blood Pressure-Lowering Strategy Using Remifentanil and Dexmedetomidine in Patients With Spontaneous Intracerebral Hemorrhage: A Multicenter, Prospective, Superiority, Randomized Controlled Trial
Lead sponsor
The Third Affiliated Hospital of Southern Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
December 31, 2028
Enrollment
1,116 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage